Insiders sell stock to diversify assets and is highly regulated and scrutinized. Insiders can only sell shares at certain times during the year, and …
Analysts are coming to the biotech round table circling the sidelines on Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Teva Pharmaceutical …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced the initiation of ADVANCE, a Phase II study to evaluate pimavanserin for adjunctive treatment in patients with negative …
It’s the final earnings cut for biotech stocks Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).
Tazeen Ahmad at Merrill Lynch, one of Wall Street’s best performing analysts, is out with newly bullish insights on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) while …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced its unaudited financial results for the third quarter ended September 30, 2016.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced the initiation of ENHANCE-1, a Phase III study to evaluate pimavanserin for adjunctive treatment of schizophrenia in patients with …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced the initiation of SERENE, a Phase II study with pimavanserin for the treatment of agitation in patients with Alzheimer’s …
Needham analyst Alan Carr weighs in on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after hosting a call last week with key opinion leader (KOL) Dr.
In a research report released today, Roth Capital analyst Michael Higgins resumed coverage on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a Neutral rating on …
